Gilead has gotten a new HIV preventive treatment, Yeztugo, approved, which consists of two injections a year, promising more effective prevention.
Lara Maior
Current Affairs
Foto Gilead Pharma
Always see our news on Google
Yeztugo, a drug developed by Gilead, has been authorized in the United States as a preventive treatment against HIV. It requires only two injections a year, unlike current treatments that require daily pills. While the treatment could revolutionize the fight against the AIDS epidemic, cost remains a crucial issue, with an estimated annual price tag of about $25,000. UNAIDS director Winnie Byanyima emphasized the importance of making the drug affordable to have a real impact in the fight against AIDS.
Sources
Tratament promiţător împotriva HIV-SIDA. Producătorii promit prețuri accesibil
Statele Unite autorizează un nou tratament preventiv, foarte promiţător, împotriva HIV, virusul care cauzează SIDA
FDA approves first twice-yearly injection that prevents HIV infection
US approves promising preventive HIV treatment
Groundbreaking twice-a-year HIV drug that could stop transmission approved
Latest News
16:11
Robert Cerari was elected baron of the Roma in the Republic of Moldova, succeeding his father, Artur Cerari. The elections took place with unanimous votes.
16:01
North Korea accuses Japan of preparations for an 'aggressive war' following the announcement regarding the increase of the defense budget to 8.9 trillion yen
15:50
Five people were injured in an accident between an ambulance on a mission and a car on Calea Feldioarei in Brașov.
15:42
The water supply in Neamț County is in a critical situation, prefect Maria Apostol has requested urgent interventions from the authorities.
See more news
NEWS ON THE SAME TOPICS
.webp)
.webp)
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
